Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!



Rating:

Share or cite this content

Citations should be made in the following way:
L. Uller (Lund, Sweden). Macrolides targeting multiple immune pathways in asthma and COPD. Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!

Member's Comments

No comment yet.

Related content which might interest you: Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations Source: Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016 Year: 2017 Inflammatory phenotypes of asthma determine effect of inhaled corticosteroids on anti-viral immunity Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Targeting traits in asthma and COPD Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target! Year: 2021 LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019 The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Targeting the epigenome in asthma and COPD Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 The features of cellular immunity in patients with treatment-resistant asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease Source: Eur Respir J 2007; 30: 383-390 Year: 2007 The role of response to bronchodilators in differential diagnosis of COPD and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003 How cultured epithelial cells from asthma and COPD patients deal with pathogens: defective anti-rhinovirus responses in asthma Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 The role of viral infections in asthma and asthma exacerbations Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma Year: 2010 The adaptive immune system, autoimmunity and COPD: lessons from human studies Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD? Year: 2007 Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD Source: Eur Respir J 2013; 42: 891-892 Year: 2013 Photobiomodulation acting as an immunotherapeutic strategy for chronic obstructive diseases such as asthma and COPD Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 JAK/STATs in asthma and COPD Source: Annual Congress 2004 - Transcription factors in airway disease Year: 2004